UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Experiences with fluorescence diagnosis and photodynamic therapy in a multimodality therapy concept of operated, recurrent bronchial carcinoma

Pneumologie (Stuttgart, Germany), 1996-10, Vol.50 (10), p.693

1996

Volltextzugriff (PDF)

Glycine receptor autoantibodies disrupt inhibitory neurotransmission

Brain (London, England : 1878), 2019-11, Vol.142 (11), p.3398-3410

2019

Volltextzugriff (PDF)

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

Annals of oncology, 2019-11, Vol.30 (11), p.1796-1803

2019

Volltextzugriff (PDF)

Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy

Journal of cancer research and clinical oncology, 2013-04, Vol.139 (4), p.681-689

2013

Volltextzugriff (PDF)

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

The lancet oncology, 2013-05, Vol.14 (6), p.490-499

2013

Volltextzugriff (PDF)

β−Adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder

Cell and tissue research, 2010-11, Vol.342 (2), p.295-306

2010

Volltextzugriff (PDF)

Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’

European journal of cancer (1990), 2018-05, Vol.94, p.95-103

2018

Volltextzugriff (PDF)

Changes in the severity and subtype of Guillain-Barré syndrome admitted to a specialist Neuromedical ICU over a 25 year period

Journal of neurology, 2017-03, Vol.264 (3), p.564-569

2017

Volltextzugriff (PDF)

Outcome of ventilatory support for acute respiratory failure in motor neurone disease

Journal of neurology, neurosurgery and psychiatry, 2002-06, Vol.72 (6), p.752-756

2002

Volltextzugriff (PDF)

PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation

Annals of neurology, 2019-08, Vol.86 (2), p.225-240

2019

Volltextzugriff (PDF)

Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

European journal of cancer (1990), 2019-01, Vol.106, p.115-125

2019

Volltextzugriff (PDF)

Use of Self-Expandable Plastic Stents For the Treatment of Esophageal Perforations and Symptomatic Anastomotic Leaks

Endoscopy, 2004-08, Vol.36 (8), p.695-699

2004

Volltextzugriff (PDF)

Cetuximab plus gemcitabine oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

British journal of cancer, 2009-04, Vol.100 (7), p.1032-1036

2009

Volltextzugriff (PDF)

Myasthenia gravis - treatment of acute severe exacerbations in the intensive care unit results in a favourable long-term prognosis

European journal of neurology, 2014-01, Vol.21 (1), p.171-173

2014

Volltextzugriff (PDF)

CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

Annals of oncology, 2016-08, Vol.27 (8), p.1565-1572

2016

Volltextzugriff (PDF)

KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy

Oncology, 2011-01, Vol.81 (1), p.3-8

2011

Volltextzugriff (PDF)

Thymectomy: role in the treatment of myasthenia gravis

Journal of neurology, 2013-07, Vol.260 (7), p.1798-1801

2013

Volltextzugriff (PDF)

Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease

International journal of colorectal disease, 2006-03, Vol.21 (2), p.97-104

2006

Volltextzugriff (PDF)

Diagnostic microsatellite instability : Definition and correlation with mismatch repair protein expression

Cancer research (Chicago, Ill.), 1997-11, Vol.57 (21), p.4749-4756

1997

Volltextzugriff (PDF)

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

The lancet. Gastroenterology & hepatology, 2021-02, Vol.6 (2), p.128-138

2021

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis

Muscle & nerve, 2013-07, Vol.48 (1), p.76-84

2013

Volltextzugriff (PDF)

Myasthenia gravis

BMJ (Online), 2012-12, Vol.345, p.e8497

2012

Volltextzugriff (PDF)

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

British journal of cancer, 2005-07, Vol.93 (2), p.190-194

2005

Volltextzugriff (PDF)

Application of a Time-Varying Covariate Model to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced Pancreatic Cancer

Clinical cancer research, 2010-02, Vol.16 (3), p.986-994

2010

Volltextzugriff (PDF)

Self-expanding Polyflex plastic stents in esophageal disease : various indications, complications, and outcomes

Surgical endoscopy, 2007-06, Vol.21 (6), p.889-896

2007

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(54)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(54)
Female
(48)
Life Sciences & Biomedicine
(47)
Middle Aged
(47)
Science & Technology
(47)
Male
(46)
Adult
(37)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Oncology
(15)
Adolescent
(13)
Aged, 80 And Over
(13)
Treatment Outcome
(13)
Gastroenterology & Hepatology
(12)
Tumors
(12)
Gastroenterology. Liver. Pancreas. Abdomen
(11)
Retrospective Studies
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Clinical Neurology
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Experiences with fluorescence diagnosis and photodynamic therapy in a multimodality therapy concept of operated, recurrent bronchial carcinoma

Glycine receptor autoantibodies disrupt inhibitory neurotransmission

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

β−Adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder

Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’

Changes in the severity and subtype of Guillain-Barré syndrome admitted to a specialist Neuromedical ICU over a 25 year period

Outcome of ventilatory support for acute respiratory failure in motor neurone disease

PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation

Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

Use of Self-Expandable Plastic Stents For the Treatment of Esophageal Perforations and Symptomatic Anastomotic Leaks

Cetuximab plus gemcitabine oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

Myasthenia gravis - treatment of acute severe exacerbations in the intensive care unit results in a favourable long-term prognosis

CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy

Thymectomy: role in the treatment of myasthenia gravis

Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease

Diagnostic microsatellite instability : Definition and correlation with mismatch repair protein expression

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis

Myasthenia gravis

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

Application of a Time-Varying Covariate Model to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced Pancreatic Cancer

Self-expanding Polyflex plastic stents in esophageal disease : various indications, complications, and outcomes

Aktive Filter

Suchergebnisse filtern